VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹315 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹137 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 12.61 | |
| Mar2024 | ₹280 Cr | 16.58 | |
| Mar2023 | ₹240 Cr | 29.66 | |
| Mar2022 | ₹185 Cr | 35.66 | |
| Mar2021 | ₹137 Cr | - | |
Compare Net Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,230.6 Cr | -10.9% | 6.8% | 275.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -10.9% |
6.8% |
275.1% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses